13F filing recap · Q4 2010

What did Wedgewood Partners buy in Q4 2010?

Reported stock-position changes between this filing and the previous one. US-listed stocks across every Wedgewood account, including accounts that belong to no fund below.

Stock value

$580.18M

Positions

Estimated turnover

18.3%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

USBUS Bancorp$30.61Mreported value+1.14M shares ISRGIntuitive Surgical, Inc.$14.68Mreported value+56.9K shares

Increased positions

AAPLApple Inc.$51.57Mreported value+4.8K shares+3.1%ESRXExpress Scripts Holding Co.$43.79Mreported value+19.6K shares+2.5%GOOGLAlphabet Inc.$41.10Mreported value+1.9K shares+2.8%VVisa Inc.$38.66Mreported value+22.7K shares

Reduced positions

GILDGilead Sciences, Inc.$31.88Mreported value-122.8K shares-12.3%VARVarian Medical Systems, Inc.$24.53Mreported value-2.2K shares-0.6%EXPDExpeditors International of Washington, Inc.$12.47Mreported value-268.6K shares-54.0%